In the Lab By Rick Berke Alarmed by new ‘CRISPR babies’ plan, top science figures say they’re powerless to stop it
First Opinion By Nina Frahm and Tess Doezema Are scientists’ reactions to ‘CRISPR babies’ about ethics or self-governance?
In the Lab By Andrew Joseph Watch: As it moves out of the lab, CRISPR brings tough questions into the clinic
Adam's Take By Adam Feuerstein Preclinical biotech companies are having an IPO bonanza. What’s the draw for investors?
In the Lab By Charles Piller California considers funding controversial research: editing genes in human embryos
In the Lab By Andrew Joseph and Sharon Begley God, malaria, and wolverine claws: Colbert talks CRISPR with George Church